Charles Wolf, president of Initiative Pharma: facing the "wall" of ageing, "we will have to invest in health"
As the presentation of the 2027 Social Security budget approaches, the president of the new employers' union in the pharmaceutical industry is calling for innovative drugs produced or developed in France to be given greater value. He ensures that these additional expenses will benefit the country's economy.
We haven't written up this one. Le Monde Economie has the full story — the link below goes straight to it.
